Background: It is not long before the outbreak of coronavirus disease (COVID-19) and its transformation into a pandemic. Over the course of late December 2019, studies have shown that cardiovascular comorbidities are more common in patients with COVID-19 and that these patients are at higher risk for complications and mortality; however, it is not yet clear whether underlying cardiovascular diseases pose a separate risk or whether they are associated with other factors, such as age and sex. The purpose of this study is to review the underlying cardiovascular diseases during the COVID-19. For this purpose, the main review articles using keywords such as “COVID-19”, ‘Coronavirus”, “SARS-CoV-2”, “Cardiovascular diseases”, “Myocarditis”, “Acute coronary syndromes”, “Heart failure”, and “Ischemic heart disease: were collected from PubMed, Scopus, Google Scholar, Web of Science and other reputable databases. The results showed that myocardial injury was present in more than 25% of critical cases and appeared in two patterns: acute myocardial injury and dysfunction during the presentation and myocardial injury caused by exacerbation of the disease. Continuation of angiotensin converting enzyme inhibitors and angiotensin receptor inhibitors is recommended based on the evidence at this time. A number of promising therapies are under consideration, but none have been clinically proven to be effective to date. The present study indicates that during the corona pandemic, more attention should be paid to people with cardiovascular disease and effective treatments should be used for them based on new studies.

Keywords: Heart failure, Coronavirus diseases, Acute coronary syndrome, Treatment, Myocarditis

Full-Text [PDF 322 kb]   (1631 Downloads)